Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

Tert-butyl benzoquinone: mechanism of biofilm eradication and potential for use as a topical antibiofilm agent.

Ooi N, Eady EA, Cove JH, O'Neill AJ.

J Antimicrob Chemother. 2016 Jul;71(7):1841-4. doi: 10.1093/jac/dkw100. Epub 2016 Apr 27.

2.

Redox-active compounds with a history of human use: antistaphylococcal action and potential for repurposing as topical antibiofilm agents.

Ooi N, Eady EA, Cove JH, O'Neill AJ.

J Antimicrob Chemother. 2015 Feb;70(2):479-88. doi: 10.1093/jac/dku409. Epub 2014 Nov 3.

3.

A honey trap for the treatment of acne: manipulating the follicular microenvironment to control Propionibacterium acnes.

Eady EA, Layton AM, Cove JH.

Biomed Res Int. 2013;2013:679680. doi: 10.1155/2013/679680. Epub 2013 May 14.

4.

Interleukin-10 secretion from CD14+ peripheral blood mononuclear cells is downregulated in patients with acne vulgaris.

Caillon F, O'Connell M, Eady EA, Jenkins GR, Cove JH, Layton AM, Mountford AP.

Br J Dermatol. 2010 Feb 1;162(2):296-303. doi: 10.1111/j.1365-2133.2009.09420.x. Epub 2009 Jul 20.

PMID:
19796181
5.

Temporal changes in sebum excretion and propionibacterial colonization in preadolescent children with and without acne.

Mourelatos K, Eady EA, Cunliffe WJ, Clark SM, Cove JH.

Br J Dermatol. 2007 Jan;156(1):22-31.

PMID:
17199562
6.

Efficacy of oral isotretinoin in the control of skin and nasal colonization by antibiotic-resistant propionibacteria in patients with acne.

Coates P, Vyakrnam S, Ravenscroft JC, Stables GI, Cunliffe WJ, Leyden JJ, Johnson J, Eady EA, Cove JH.

Br J Dermatol. 2005 Dec;153(6):1126-36. Erratum in: Br J Dermatol. 2006 Apr;154(4):807.

PMID:
16307647
7.

ABC proteins and antibiotic drug resistance: is it all about transport?

Kerr ID, Reynolds ED, Cove JH.

Biochem Soc Trans. 2005 Nov;33(Pt 5):1000-2.

PMID:
16246031
8.

Resistance to telithromycin is conferred by msr(A), msrC and msr(D) in Staphylococcus aureus.

Reynolds ED, Cove JH.

J Antimicrob Chemother. 2005 Dec;56(6):1179-80. Epub 2005 Oct 13. No abstract available.

PMID:
16223938
9.

Enhanced resistance to erythromycin is conferred by the enterococcal msrC determinant in Staphylococcus aureus.

Reynolds E, Cove JH.

J Antimicrob Chemother. 2005 Feb;55(2):260-4. Epub 2005 Jan 13.

PMID:
15649995
10.
11.

Msr(A) and related macrolide/streptogramin resistance determinants: incomplete transporters?

Reynolds E, Ross JI, Cove JH.

Int J Antimicrob Agents. 2003 Sep;22(3):228-36.

PMID:
13678826
12.

Correlation between enterococcal biofilm formation in vitro and medical-device-related infection potential in vivo.

Sandoe JA, Witherden IR, Cove JH, Heritage J, Wilcox MH.

J Med Microbiol. 2003 Jul;52(Pt 7):547-50.

PMID:
12808074
13.

Short-term effects of topical fusidic acid or mupirocin on the prevalence of fusidic acid resistant (FusR) Staphylococcus aureus in atopic eczema.

Ravenscroft JC, Layton AM, Eady EA, Murtagh MS, Coates P, Walker M, Cove JH.

Br J Dermatol. 2003 May;148(5):1010-7.

PMID:
12786834
15.

Cytolysin gene expression in Enterococcus faecalis is regulated in response to aerobiosis conditions.

Day AM, Cove JH, Phillips-Jones MK.

Mol Genet Genomics. 2003 Apr;269(1):31-9. Epub 2003 Feb 22.

PMID:
12715151
16.

Antibiotic-resistant acne: lessons from Europe.

Ross JI, Snelling AM, Carnegie E, Coates P, Cunliffe WJ, Bettoli V, Tosti G, Katsambas A, Galvan Peréz Del Pulgar JI, Rollman O, Török L, Eady EA, Cove JH.

Br J Dermatol. 2003 Mar;148(3):467-78.

PMID:
12653738
17.

Prevalence of antibiotic-resistant propionibacteria on the skin of acne patients: 10-year surveillance data and snapshot distribution study.

Coates P, Vyakrnam S, Eady EA, Jones CE, Cove JH, Cunliffe WJ.

Br J Dermatol. 2002 May;146(5):840-8.

PMID:
12000382
18.
19.

Is acne an infection of blocked pilosebaceous follicles? Implications for antimicrobial treatment.

Eady EA, Cove JH.

Am J Clin Dermatol. 2000 Jul-Aug;1(4):201-9. Review.

PMID:
11702364
20.

Evaluation of a biochemical test scheme for identifying clinical isolates of Enterococcus faecalis and Enterococcus faecium.

Day AM, Sandoe JA, Cove JH, Phillips-Jones MK.

Lett Appl Microbiol. 2001 Nov;33(5):392-6.

21.

Mutation frequencies for resistance to fusidic acid and rifampicin in Staphylococcus aureus.

O'Neill AJ, Cove JH, Chopra I.

J Antimicrob Chemother. 2001 May;47(5):647-50.

PMID:
11328777
22.

Phenotypic and genotypic characterization of antibiotic-resistant Propionibacterium acnes isolated from acne patients attending dermatology clinics in Europe, the U.S.A., Japan and Australia.

Ross JI, Snelling AM, Eady EA, Cove JH, Cunliffe WJ, Leyden JJ, Collignon P, Dréno B, Reynaud A, Fluhr J, Oshima S.

Br J Dermatol. 2001 Feb;144(2):339-46.

PMID:
11251569
23.
24.

A variety of gram-positive bacteria carry mobile mef genes.

Luna VA, Coates P, Eady EA, Cove JH, Nguyen TT, Roberts MC.

J Antimicrob Chemother. 1999 Jul;44(1):19-25.

PMID:
10459806
25.

16S rRNA mutation associated with tetracycline resistance in a gram-positive bacterium.

Ross JI, Eady EA, Cove JH, Cunliffe WJ.

Antimicrob Agents Chemother. 1998 Jul;42(7):1702-5.

26.

Inflammation in acne vulgaris: failure of skin micro-organisms to modulate keratinocyte interleukin 1 alpha production in vitro.

Ingham E, Walters CE, Eady EA, Cove JH, Kearney JN, Cunliffe WJ.

Dermatology. 1998;196(1):86-8. No abstract available.

PMID:
9557236
27.

Resistance to erythromycin and clindamycin in cutaneous propionibacteria is associated with mutations in 23S rRNA.

Ross JI, Eady EA, Cove JH, Ratyal AH, Cunliffe WJ.

Dermatology. 1998;196(1):69-70. No abstract available.

PMID:
9557230
28.

Cutaneous antimicrobial defense.

Cove JH, Eady EA.

Clin Dermatol. 1998 Jan-Feb;16(1):141-7. Review. No abstract available.

PMID:
9472444
29.

Clinical resistance to erythromycin and clindamycin in cutaneous propionibacteria isolated from acne patients is associated with mutations in 23S rRNA.

Ross JI, Eady EA, Cove JH, Jones CE, Ratyal AH, Miller YW, Vyakrnam S, Cunliffe WJ.

Antimicrob Agents Chemother. 1997 May;41(5):1162-5.

30.

Comparison of serum antibiotic levels in acne patients receiving the standard or a modified release formulation of minocycline hydrochloride.

Gardner KJ, Eady EA, Cove JH, Taylor JP, Cunliffe WJ.

Clin Exp Dermatol. 1997 Mar;22(2):72-6.

PMID:
9330069
31.
32.

Sequential antibiotic therapy for acne promotes the carriage of resistant staphylococci on the skin of contacts.

Miller YW, Eady EA, Lacey RW, Cove JH, Joanes DN, Cunliffe WJ.

J Antimicrob Chemother. 1996 Nov;38(5):829-37.

PMID:
8961052
33.

The effects of acne treatment with a combination of benzoyl peroxide and erythromycin on skin carriage of erythromycin-resistant propionibacteria.

Eady EA, Bojar RA, Jones CE, Cove JH, Holland KT, Cunliffe WJ.

Br J Dermatol. 1996 Jan;134(1):107-13.

PMID:
8745894
34.

Depression of streptomycin production by Streptomyces griseus at elevated growth temperature: studies using gene fusions.

Deeble VJ, Lindley HK, Fazeli MR, Cove JH, Baumberg S.

Microbiology. 1995 Oct;141 ( Pt 10):2511-8.

PMID:
7582010
35.

The use of PCR to isolate a putative ABC transporter from Saccharopolyspora erythraea.

O'Neill MP, Eady EA, Radford A, Baumberg S, Cove JH.

FEMS Microbiol Lett. 1995 Sep 1;131(2):189-95.

PMID:
7557329
37.
38.

Physiological factors affecting streptomycin production by Streptomyces griseus ATCC 12475 in batch and continuous culture.

Reza Fazeli M, Cove JH, Baumberg S.

FEMS Microbiol Lett. 1995 Feb 1;126(1):55-61.

PMID:
7896077
39.

Variation in comedonal antibiotic concentrations following application of topical tetracycline for acne vulgaris.

Gardner KJ, Cunliffe WJ, Eady EA, Cove JH.

Br J Dermatol. 1994 Nov;131(5):649-54.

PMID:
7999595
40.
41.

Modulation of comedonal levels of interleukin-1 in acne patients treated with tetracyclines.

Eady EA, Ingham E, Walters CE, Cove JH, Cunliffe WJ.

J Invest Dermatol. 1993 Jul;101(1):86-91.

42.

Tetracycline-resistant propionibacteria from acne patients are cross-resistant to doxycycline, but sensitive to minocycline.

Eady EA, Jones CE, Gardner KJ, Taylor JP, Cove JH, Cunliffe WJ.

Br J Dermatol. 1993 May;128(5):556-60.

PMID:
8504049
43.

Antibiotic resistant propionibacteria in acne: need for policies to modify antibiotic usage.

Eady EA, Jones CE, Tipper JL, Cove JH, Cunliffe WJ, Layton AM.

BMJ. 1993 Feb 27;306(6877):555-6. No abstract available.

44.

Distribution of genes encoding erythromycin ribosomal methylases and an erythromycin efflux pump in epidemiologically distinct groups of staphylococci.

Eady EA, Ross JI, Tipper JL, Walters CE, Cove JH, Noble WC.

J Antimicrob Chemother. 1993 Feb;31(2):211-7.

PMID:
8463168
45.

Pro-inflammatory levels of interleukin-1 alpha-like bioactivity are present in the majority of open comedones in acne vulgaris.

Ingham E, Eady EA, Goodwin CE, Cove JH, Cunliffe WJ.

J Invest Dermatol. 1992 Jun;98(6):895-901.

46.

Plasmid effects on secondary metabolite production by a streptomycete synthesizing an anthelmintic macrolide.

Thomas DI, Cove JH, Baumberg S, Jones CA, Rudd BA.

J Gen Microbiol. 1991 Oct;137(10):2331-7.

PMID:
1770350
47.

Inflammatory levels of interleukin 1 alpha are present in the majority of open comedones in acne vulgaris.

Eady EA, Goodwin CE, Cove JH, Ingham E, Cunliffe WJ.

Arch Dermatol. 1991 Aug;127(8):1238-9. No abstract available.

PMID:
1830734
48.

Multiple mechanisms of erythromycin resistance.

Eady EA, Ross JI, Cove JH.

J Antimicrob Chemother. 1990 Oct;26(4):461-5. No abstract available.

PMID:
2254217
49.

Inducible erythromycin resistance in staphylococci is encoded by a member of the ATP-binding transport super-gene family.

Ross JI, Eady EA, Cove JH, Cunliffe WJ, Baumberg S, Wootton JC.

Mol Microbiol. 1990 Jul;4(7):1207-14.

PMID:
2233255
50.

Skin carriage of antibiotic-resistant coagulase-negative staphylococci in untreated subjects.

Cove JH, Eady EA, Cunliffe WJ.

J Antimicrob Chemother. 1990 Mar;25(3):459-69.

PMID:
2338422

Supplemental Content

Support Center